Literature DB >> 16953158

Will absorbable metal stent technology change our practice?

M Bosiers1, K Deloose, J Verbist, P Peeters.   

Abstract

Peripheral stents aim to support revascularization procedures of intravascular stenoses by mechanically preventing vessel recoil and counteracting pathophysiologic processes of luminal re-narrowing triggered by procedural injury of the vessel wall. Despite improvements in stenting techniques and concomitant medication, repeated intervention due to target lesion re-stenosis is necessary on a significant percentage of patients. The permanent presence of an artificial implant plays a prominent role in the discussion of mechanisms causing in-stent restenosis. Permanent metallic implants pose the risk of a continuous interaction between non-absorbable stent and surrounding tissue, leading to physical irritation, long-term endothelial dysfunction, or chronic inflammatory reactions. In addition, there is a risk of stent fracture due to external mechanical forces. To overcome these shortcomings, technology of stenting has moved towards the development of temporary implants composed of biocompatible materials which mechanically support the vessel during the period of high risk for recoil and then completely degrade in the long-term perspective. This removes a potential trigger for late restenosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16953158

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  3 in total

1.  Drug-eluting stents.

Authors:  Xiaodong Ma; Tim Wu; Michael P Robich; Xingwei Wang; Hao Wu; Bryan Buchholz; Stephen McCarthy
Journal:  Int J Clin Exp Med       Date:  2010-07-15

Review 2.  Endovascular techniques in limb salvage: stents.

Authors:  Hosam F El-Sayed
Journal:  Methodist Debakey Cardiovasc J       Date:  2013-04

3.  AMS INSIGHT--absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis.

Authors:  Marc Bosiers; Patrick Peeters; Olivier D'Archambeau; Jeroen Hendriks; Ernst Pilger; Christoph Düber; Thomas Zeller; Andreas Gussmann; Paul N M Lohle; Erich Minar; Dierk Scheinert; Klaus Hausegger; Karl-Ludwig Schulte; Jürgen Verbist; Koen Deloose; J Lammer
Journal:  Cardiovasc Intervent Radiol       Date:  2008-12-18       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.